Potensi Senyawa Bioaktif dari Manilkara zapota sebagai Agen Antiporosis melalui Pendekatan In Silico terhadap Protein RANKL (3URF)

Osteoporosis is characterized by reduced bone mass and an imbalance between bone formation and resorption. Receptor activator of nuclear factor kappa-B ligand (RANKL) plays an important role in osteoclast differentiation, making it a potential target for the development of osteoporosis therapies. This study aimed to evaluate the potential of bioactive compounds from Manilkara zapota as candidate antiosteoporosis agents through an in silico approach using molecular docking against the RANKL protein (PDB ID: 3URF). Ten bioactive compounds were used as test ligands, with denosumab as the positive control. The study stages included protein and ligand preparation, redocking validation, molecular docking, drug-likeness evaluation, and ADMET prediction. Redocking yielded an RMSD value of 0.8827 Å. All test compounds yielded negative binding affinity scores against RANKL, indicating potential ligand–protein interactions based on computational modeling. Most compounds met the drug-likeness criteria and were predicted to have favorable ADMET profiles, whereas myricetin-3-O-glucoside and chlorogenic acid did not meet several drug-likeness parameters. These findings provide a preliminary computational basis for exploring bioactive compounds from M. zapota as candidate antiosteoporosis agents. However, docking scores and predicted pharmacokinetic properties do not yet demonstrate the compounds’ biological activity, effectiveness, or safety, making further in vitro and in vivo testing necessary.

Authors

Publication Details

Journal
MASALIQ
Published
2026-11-14
DOI
https://doi.org/10.58578/masaliq.v6i6.12640
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Potensi Senyawa Bioaktif dari Manilkara zapota sebagai Agen Antiporosis melalui Pendekatan In Silico terhadap Protein RANKL (3URF)

Alizar Ulianas, intan elwis khairina muzia
MASALIQ
Computational Drug Discovery Methods
article

Potensi Senyawa Bioaktif dari Manilkara zapota sebagai Agen Antiporosis melalui Pendekatan In Silico terhadap Protein RANKL (3URF)

Alizar Ulianas, intan elwis khairina muzia
article en

Abstract

Osteoporosis is characterized by reduced bone mass and an imbalance between bone formation and resorption. Receptor activator of nuclear factor kappa-B ligand (RANKL) plays an important role in osteoclast differentiation, making it a potential target for the development of osteoporosis therapies. This study aimed to evaluate the potential of bioactive compounds from Manilkara zapota as candidate antiosteoporosis agents through an in silico approach using molecular docking against the RANKL protein (PDB ID: 3URF). Ten bioactive compounds were used as test ligands, with denosumab as the positive control. The study stages included protein and ligand preparation, redocking validation, molecular docking, drug-likeness evaluation, and ADMET prediction. Redocking yielded an RMSD value of 0.8827 Å. All test compounds yielded negative binding affinity scores against RANKL, indicating potential ligand–protein interactions based on computational modeling. Most compounds met the drug-likeness criteria and were predicted to have favorable ADMET profiles, whereas myricetin-3-O-glucoside and chlorogenic acid did not meet several drug-likeness parameters. These findings provide a preliminary computational basis for exploring bioactive compounds from M. zapota as candidate antiosteoporosis agents. However, docking scores and predicted pharmacokinetic properties do not yet demonstrate the compounds’ biological activity, effectiveness, or safety, making further in vitro and in vivo testing necessary.

MASALIQVol. 6(6)
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon